BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL
6739 results:

  • 1. Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
    Marvaso G; Jereczek-Fossa BA; Zaffaroni M; Vincini MG; Corrao G; Andratschke N; Balagamwala EH; Bedke J; Blanck O; Capitanio U; Correa RJM; De Meerleer G; Franzese C; Gaeta A; Gandini S; Garibaldi C; Gerszten PC; Gillessen S; Grubb WR; Guckenberger M; Hannan R; Jhaveri PM; Josipovic M; Kerkmeijer LGW; Lehrer EJ; Lindskog M; Louie AV; Nguyen QN; Ost P; Palma DA; Procopio G; Rossi M; Staehler M; Tree AC; Tsang YM; Van As N; Zaorsky NG; Zilli T; Pasquier D; Siva S
    Lancet Oncol; 2024 May; 25(5):e193-e204. PubMed ID: 38697165
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epidemiology, treatment and outcomes of primary renal sarcomas in adult patients.
    Uhlig J; Uhlig A; Deshpande H; Ströbel P; Trojan L; Lotz J; Hurwitz M; Hafez O; Humphrey P; Grünwald V; Kim HS
    Sci Rep; 2024 May; 14(1):10038. PubMed ID: 38693188
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
    Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
    JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of the perioperative outcomes of robot-assisted laparoscopic transperitoneal versus retraperitoneal partial nephrectomy for posterior-lateral renal tumors: a systematic review and meta-analysis.
    Xu P; Luo J; Shuai H; Cai T; Cui S; Zhou L; Xu Q; Zhao Y; Chen T; Shan W; Wu T
    J Robot Surg; 2024 Apr; 18(1):186. PubMed ID: 38683492
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.
    Pitakkitnukun P; Pongpitakmetha T; Suttichet TB; Sukkummee W; Chariyavilaskul P; Polprasert C
    Sci Rep; 2024 Apr; 14(1):9695. PubMed ID: 38678107
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
    Pei F; Tao Z; Lu Q; Fang T; Peng S
    World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease.
    Li H; Huntington S; Gross C; Wang SY
    PLoS One; 2024; 19(4):e0300789. PubMed ID: 38625861
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A case of pancreatic PEComa with prominent inflammatory cell infiltration: the inflammatory subtype is a distinct histologic group of PEComa.
    Tsukita H; Koyama K; Ishinari T; Takahashi A; Miyabe K; Umakoshi M; Yoshida M; Kudo-Asabe Y; Nishida A; Otsuka N; Yasui O; Kato I; Fukushima N; Goto A
    Diagn Pathol; 2024 Apr; 19(1):59. PubMed ID: 38622713
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Preliminary Investigation of a Rapid and Feasible Therapeutic Drug Monitoring Method for the Real-Time Estimation of Blood Pazopanib Concentrations.
    Kato M; Maruyama S; Watanabe N; Yamada R; Suzaki Y; Ishida M; Kanno H
    AAPS J; 2024 Apr; 26(3):48. PubMed ID: 38622446
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Robotic salvage partial nephrectomy following surgical and ablative therapies.
    Feng CL; Franco A; Ditonno F; Manfredi C; Chow AK; Autorino R
    Int Braz J Urol; 2024; 50(3):373-374. PubMed ID: 38598832
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical safety and efficacy of microwave ablation for small renal masses.
    Foret A; Haaga CB; Jain S; Baumgartner CO; Escott M; Henderson BR; O'Brien ST; Delacroix SE; Gills JRR; Westerman ME
    Int Braz J Urol; 2024; 50(3):277-286. PubMed ID: 38598830
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Challenges and technical aspects in the management of muscle invasive bladder cancer as retrograde radical cystectomy with ileal conduit.
    Nusrat NB; Rehman AU; Zafar N; Muhammad S; Bajwa SI; Imtiaz S
    J Pak Med Assoc; 2024 Mar; 74(3):513-518. PubMed ID: 38591289
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Open versus robotic partial nephrectomy in obese patients: a multi-institutional propensity score-matched analysis (UroCCR 43-Robese study).
    Beauval JB; Khene ZE; Roumiguié M; Rahota R; Mejean A; Doumerc N; Roupret M; Paparel P; Villers A; Bruyere F; Lebacle C; Nouhaud FX; Champy C; de la Taille A; Lang H; Rizk J; Durand M; Dariane C; Charles T; Boissier R; Long JA; Bigot P; Bensalah K; Bernhard JC
    World J Urol; 2024 Apr; 42(1):213. PubMed ID: 38581466
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Investigating the causal associations between metabolic biomarkers and the risk of kidney cancer.
    Lin L; Tang Y; Ning K; Li X; Hu X
    Commun Biol; 2024 Apr; 7(1):398. PubMed ID: 38561482
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
    Machiels JP; Tao Y; Licitra L; Burtness B; Tahara M; Rischin D; Alves G; Lima IPF; Hughes BGM; Pointreau Y; Aksoy S; Laban S; Greil R; Burian M; Hetnał M; Delord JP; Mesía R; Taberna M; Waldron JN; Simon C; Grégoire V; Harrington KJ; Swaby RF; Zhang Y; Gumuscu B; Bidadi B; Siu LL;
    Lancet Oncol; 2024 May; 25(5):572-587. PubMed ID: 38561010
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long-term outcome of surgically treated and conservatively managed Rathke cleft cysts.
    Schmutzer-Sondergeld M; Weller J; Thorsteinsdottir J; Schichor C; Rachinger W; Thon N; Ueberschaer M
    Acta Neurochir (Wien); 2024 Apr; 166(1):159. PubMed ID: 38557782
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
    Kim S; Ghiringhelli F; de la Fouchardière C; Evesque L; Smith D; Badet N; Samalin E; Lopez-Trabada Ataz D; Parzy A; Desramé J; Baba Hamed N; Buecher B; Tougeron D; Bouché O; Dahan L; Chibaudel B; El Hajbi F; Mineur L; Dubreuil O; Ben Abdelghani M; Pecout S; Bibeau F; Herfs M; Garcia ML; Meurisse A; Vernerey D; Taïeb J; Borg C
    Lancet Oncol; 2024 Apr; 25(4):518-528. PubMed ID: 38547895
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. National clinical and financial outcomes associated with acute kidney injury following esophagectomy for cancer.
    Ng AP; Chervu N; Branche C; Bakhtiyar SS; Marzban M; Toste PA; Benharash P
    PLoS One; 2024; 19(3):e0300876. PubMed ID: 38547215
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Characteristics of adults with potential refractory chronic cough identified using an algorithm designed for administrative claims databases: A descriptive study.
    van Boemmel-Wegmann S; Altman KW; Herrera R; Pires PV; Pichardo PFA; Vora P
    Sci Prog; 2024; 107(1):368504241238080. PubMed ID: 38545797
    [No Abstract]    [Full Text] [Related]  

  • 20. Association Between Acute kidney Injury and the Trendelenburg Position Angle During Robot-assisted Radical Prostatectomy.
    Masuda H; Amemiya Y; Yagisawa N; Arai T; Yanagisawa M
    Anticancer Res; 2024 Apr; 44(4):1767-1772. PubMed ID: 38538005
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 337.